Grunnet E, Nyfors A, Hansen K B
Dermatologica. 1977;154(2):78-84. doi: 10.1159/000251036.
Ejaculates were studied from ten men with severa psoriasis treated with topical corticosteroids and from ten similar patients who had received methotrexate therapy from 1 to 9 years. It was not possible to demonstrate any unfavorable effect on the semen quality during the methotrexate therapy. The semen analysis was more frequently found normal (p = 0.04) in the methotrexate treated group, and no specific abnormality was found in spermatozoa of methotrexate-treated patients. Methotrexate therapy to male psoriatics seems safe and in agreement with this no congenital abnormalities have been reported. A remarkable number of the ejaculates had reduced sperm qualities, and it is proposed that this might be due to psoriatic lesions in the genital tract.
对10名接受局部皮质类固醇治疗的重度银屑病男性患者以及10名接受甲氨蝶呤治疗1至9年的类似患者的射精样本进行了研究。在甲氨蝶呤治疗期间,未发现对精液质量有任何不利影响。在接受甲氨蝶呤治疗的组中,精液分析结果更常显示正常(p = 0.04),且未在接受甲氨蝶呤治疗患者的精子中发现特定异常。甲氨蝶呤治疗男性银屑病患者似乎是安全的,与此相符的是,尚未有先天性异常的报告。相当数量的射精样本精子质量下降,有人提出这可能是由于生殖道的银屑病病变所致。